TARX (Tarsier Pharma) 1-Year ROIIC % : 0.00% (As of Dec. 2025)


What is Tarsier Pharma 1-Year ROIIC %?

Tarsier Pharma TARX 1-Year ROIIC % is 0.00 as of Dec. 2025.

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Tarsier Pharma's 1-Year ROIIC % for the quarter that ended in Dec. 2025 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Tarsier Pharma's 1-Year ROIIC % or its related term are showing as below:

TARX's 1-Year ROIIC % is not ranked *
in the Biotechnology industry.
Industry Median: -8.96
* Ranked among companies with meaningful 1-Year ROIIC % only.

Tarsier Pharma  (NYSE:TARX) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Tarsier Pharma 1-Year ROIIC % Related Terms

Tarsier Pharma 1-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for Tarsier Pharma's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tarsier Pharma 1-Year ROIIC % Chart

Tarsier Pharma Annual Data
Trend Dec23 Dec24 Dec25
1-Year ROIIC %
0.00 0.00 0.00

Tarsier Pharma Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
1-Year ROIIC % 0.00 0.00 0.00 0.00 0.00

TARX vs : 1-Year ROIIC % Comparison

For the Biotechnology subindustry, Tarsier Pharma's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tarsier Pharma 1-Year ROIIC % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tarsier Pharma's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Tarsier Pharma's 1-Year ROIIC % falls into.


Tarsier Pharma 1-Year ROIIC % Calculation

Tarsier Pharma's 1-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -2.554 (Dec. 2025) - -2.398 (Dec. 2024) )/( 0.427 (Dec. 2025) - 0.125 (Dec. 2024) )
=-0.156/0.302
=-51.66%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 1-Year ROIIC % →
What does a 1-Year ROIIC % of 0.00 mean?
Tarsier Pharma (TARX) has a 1-Year ROIIC % of 0.00 as of Dec. 2025. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Tarsier Pharma and its competitors.
Is Tarsier Pharma's 1-Year ROIIC % too high?
Tarsier Pharma's current 1-Year ROIIC % is 0.00.
How does Tarsier Pharma's 1-Year ROIIC % compare to ?
Tarsier Pharma's 1-Year ROIIC % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year ROIIC % for a Biotechnology company?
A good 1-Year ROIIC % depends on the Biotechnology industry context. However, 1-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year ROIIC % mean?
A high 1-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on Tarsier Pharma and its competitors. Tarsier Pharma's current 1-Year ROIIC % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tarsier Pharma stock overvalued right now?
Tarsier Pharma (TARX) has a current 1-Year ROIIC % of 0.00. The current 1-Year ROIIC % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year ROIIC % calculated?
1-Year ROIIC % is calculated from a company's financial statements. For Tarsier Pharma (TARX), the current 1-Year ROIIC % is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tarsier Pharma Business Description

Comparable Companies
Tarsier Pharma Ltd is a late clinical stage biopharmaceutical company, focused on the development and commercialization of novel pharmaceutical therapies to address unmet needs in ocular diseases with underlying inflammatory pathologies. Its dazdotuftide platform technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases, and is currently being developed as both eye drops and intravitreal injections. The company's Product Candidate Pipeline includes TRS01 and TRS02.